Waters stock hovers near 52-week high as Q2 2026 beat supports upbeat guidance
Published on 08/21/2026 at 14:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Waters Corp (US9418481035) stock is trading close to a recent 52-week high in late August 2026, supported by a strong second-quarter 2026 earnings beat and upbeat full-year guidance that signal solid demand for the company’s analytical instruments and services. As of August 20, 2026, the shares reached an intraday high of 420.3 USD and were last quoted at 420.77 USD, putting them almost exactly at that 52-week peak per a recent market report.
Q2 2026 earnings beat and double-digit growth
In its second quarter of 2026, Waters delivered adjusted earnings of $3.05 per share, coming in slightly ahead of the $3.01 consensus estimate, according to coverage of the company’s latest results. That EPS outperformance, while modest at $0.04, underscores the firm’s ability to manage costs while investing in growth.
The same report notes that revenue for Q2 2026 reached $1.64 billion, ahead of the $1.62 billion that analysts had forecast for the period, and other recent summaries cite reported revenue of $1.65 billion for the quarter, both pointing to a clear top-line beat summarized in an earnings-focused alert. This roughly $0.02-$0.03 billion revenue outperformance translates into a low-single-digit percentage beat versus expectations, but it matters because it shows demand exceeding models in a market where many peers are dealing with more uneven order patterns.
Recent analysis also highlights that Waters’ revenue in the latest quarter was up 113.3 percent compared to the same quarter a year earlier, a figure that reflects both organic growth and the impact of acquisitions as described in a detailed performance overview. For investors, that triple-digit year-over-year increase stands out, especially when compared with many other life-science tools companies that are reporting more modest single-digit gains.
Guidance signals confidence for the rest of 2026
Beyond the Q2 beat, Waters has set guidance that indicates management’s confidence in the trajectory for the second half of 2026. The company is targeting adjusted earnings per share of $3.95 to $4.05 for the third quarter of 2026, implying a further step up from the $3.05 delivered in Q2 2026 according to guidance commentary. At the midpoint, this Q3 2026 EPS range suggests an increase of about $0.95 per share versus the most recently reported quarter, underscoring expectations for stronger profitability as the year progresses.
For the full year 2026, Waters is guiding adjusted EPS to a range of $14.45 to $14.65, with recent market data indicating that this sits slightly above the latest consensus estimate of $14.52 as highlighted in a consensus-focused summary. The midpoint of this range, $14.55, is therefore a modest but meaningful lift compared to expectations and provides a numerical anchor for investors evaluating valuation multiples.
On the top line, Waters expects 2026 revenue between $6.42 billion and $6.48 billion, compared with a consensus estimate of $6.44 billion according to a guidance overview. The midpoint of the company’s range, at $6.45 billion, is fractionally higher than the consensus and builds on the Q2 2026 revenue result of $1.65 billion, implying continued growth in the back half of the year and supporting the stock’s recent strength.
Analyst sentiment and 52-week highs
The combination of a solid earnings beat and constructive guidance has fed into broadly positive analyst sentiment. One recent overview notes that Waters shares carry a consensus rating described as a moderate buy, with an average price target of $420.35 and a range that stretches from $375 to $435 as outlined in a discussion of the stock’s recent highs. With the stock recently trading at 420.77 USD as of August 20, 2026, that market level is effectively in line with the average target, suggesting that many of the near-term positives are reflected in the price.
That same report emphasizes that Waters shares hit a new 12-month high of 421.74 USD and last traded at 419.08 USD after previously closing at 415.84 USD in the high-level market recap. The move from 415.84 USD to 419.08 USD represents a gain of 3.24 USD, or roughly 0.8 percent, in that session, underscoring how investors reacted positively to the latest earnings and guidance data.
A separate report focusing on intraday price action points out that Waters stock reached a 52-week high of 420.3 USD and traded at 420.77 USD during that same late-August session in the detailed price snapshot. With a market capitalization of $41.3 billion at those levels, Waters is firmly in large-cap territory within the analytical instruments and life-science tools space, and its valuation now reflects both recent earnings momentum and the company’s long-term growth profile.
Ownership shifts and year-to-date performance
Recent filings highlight changes in institutional ownership that provide additional context for the stock’s performance. One investment firm disclosed holdings in Waters worth $35.64 million, underscoring ongoing institutional interest in the name at current valuations in a filing-based summary. Another filing shows a separate asset manager establishing a new position, confirming that the shareholder base continues to evolve as the share price approaches record territory according to a recent investment disclosure.
Short-term performance data from late August 2026 indicate that Waters shares were quoted at 404.65 USD in a CBOE real-time snapshot, representing a decline of 2.67 percent over the most recent session but a 6.38 percent gain since the start of the year as shown in a comparative chart overview. That combination suggests that despite minor pullbacks, the broader trend in 2026 has been upward, with the stock trading within a relatively tight band close to its 52-week high.
From a technical perspective, this means Waters stock is trading at levels that cluster close to both its 52-week high of 420.3 USD and its recent closing prices around the 404.65 USD mark, leaving a modest gap that can amplify short-term volatility for traders who pay attention to such thresholds in the context of recent price moves. For long-term investors, however, the more significant data points remain the sustained earnings growth, strong guidance, and supportive analyst consensus.
Business mix and representative product
Waters generates its revenue primarily by providing high-performance liquid chromatography systems, mass spectrometry instruments, and related consumables and services to customers in pharmaceuticals, life sciences, and industrial markets. The company’s portfolio is designed to support critical laboratory workflows, from drug discovery and quality control to environmental testing and food safety, helping customers deliver fast, accurate analytical results.
A representative example of this offering is the company’s high-performance LC system line, which integrates chromatography hardware, software, and columns to deliver precise separation of complex mixtures. These systems often work in tandem with mass spectrometers to provide detailed structural information on molecules, enabling scientists to identify and quantify compounds in fields like biologics development, metabolomics, and proteomics.
By combining advanced instrumentation with application-specific software and service contracts, Waters aims to create recurring revenue streams and deepen customer relationships. This model supports the kind of double-digit revenue growth seen in the latest quarter and underpins the full-year 2026 guidance that calls for revenue between $6.42 billion and $6.48 billion, representing a meaningful increase compared to earlier periods.
Stock positioning as of latest close
As of the most recent completed CBOE session on August 20, 2026, Waters shares closed at 404.65 USD, with data indicating a single-session decline of 2.67 percent but a year-to-date gain of 6.38 percent at that price level based on the latest quote snapshot. That closing price places the stock within less than 4 percent of its recent 52-week high of 420.3 USD, emphasizing how strongly the shares have responded to the company’s Q2 2026 earnings beat and its raised outlook for the year.
Go deeper
For readers interested in more detail on Waters stock, the recent Q2 2026 results and subsequent guidance commentary provide a rich set of metrics on segment performance, margin trends, and capital allocation decisions that can help frame long-term expectations.
Investor Relations
More on Waters stock and its latest financial communications can be found through the company’s official investor materials, which offer full quarterly reports, presentations, and regulatory filings that complement the summarized figures cited here.
Fact box
Company: Waters Corp
ISIN: US9418481035
Ticker: WAT
Exchange: NYSE
Price (as of August 20, 2026, 9:59 p.m. ET): $404.65 USD
Market cap: $41.3 billion (as of August 20, 2026)
Sector / Industry: Life sciences tools and services / Analytical instruments
Index membership: S&P 500
